Dr Catherine Bongka Baye Easton, MD, MSPH in Harrisburg, PA - Medicare Student in an Organized Health Care Education/Training Program

Dr Catherine Bongka Baye Easton, MD, MSPH is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Harrisburg, Pennsylvania. Her current practice location is 205 S Front St, Harrisburg, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at (717) 231-8494.

Dr Catherine Bongka Baye Easton is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1518596105.

Contact Information

	Dr Catherine Bongka Baye Easton, MD, MSPH
	205 S Front St, Harrisburg, PA 17104-1619
	(717) 231-8494
	Not Available

Physician's Profile

Full Name	Dr Catherine Bongka Baye Easton
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	205 S Front St, Harrisburg, Pennsylvania
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1518596105
Provider Enumeration Date: 04/06/2020
Last Update Date: 01/19/2021

Medicare PECOS Information:

PECOS PAC ID: 8224450770
Enrollment ID: I20200630000370

Medical Identifiers

Medical identifiers for Dr Catherine Bongka Baye Easton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518596105	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	MT219772 (Pennsylvania)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Catherine Bongka Baye Easton is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Catherine Bongka Baye Easton, MD, MSPH 204 Mary St Apt 19, Harrisburg, PA 17104-3523 Ph: (571) 471-7353	Dr Catherine Bongka Baye Easton, MD, MSPH 205 S Front St, Harrisburg, PA 17104-1619 Ph: (717) 231-8494

News Archive

Viewpoints: Health law's threat to individual liberty; Conflicting opinions on the constitutionality of the individual mandate

On Monday, the Supreme Court will begin an extraordinary three-day hearing on the constitutionality of ObamaCare. At stake are the Constitution's structural guarantees of individual liberty, which limit governmental power and ensure political accountability by dividing that power between federal and state authorities. Upholding ObamaCare would destroy this dual-sovereignty system, the most distinctive feature of American constitutionalism.

BioMarin Pharmaceutical signs stock purchase agreement to acquire LEAD Therapeutics

BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.

American scientists develop simple system to detect influenza virus from nasal or throat swabs

Almost every winter sees a new wave of influenza, threatening people by its highly contagious character and severe pathogenesis if those with weak or compromised immune system are infected. But when do sniffing and high temperature only point to a bad cold and when is it real influenza? American scientists have developed a simple system for testing for the influenza virus by just taking nasal or throat swabs and measuring the viral presence amperometrically by assessing the glucose level.

Caraco Pharmaceutical Laboratories commences marketing of rivastigmine tartrate capsules

Caraco Pharmaceutical Laboratories, Ltd. has started shipping rivastigmine tartrate capsules. These products, approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA), are therapeutically equivalent to Exelon® capsules from Novartis.

Dr Catherine Bongka Baye Easton, MD, MSPH - Medicare Student in an Organized Health Care Education/Training Program in Harrisburg, PA